MAGEA3 and ovarian carcinoma: Szajnik et al. found from 22 patients’ plasma samples that TGF-beta and MAGE3/6 proteins present on exosomes can distinguish ovarian carcinoma from benign tumors or nontumor tissues, and the levels of these tumor-associated proteins correlate with patients’ responses to therapy [75].